Status:
UNKNOWN
Less Frequency Hemodialysis and COVID-19
Lead Sponsor:
Dialisis Madariaga
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Facing the unusual situation imposed by the coronavirus disease, the aim of this study is to evaluate the risk and effects of less frequent hemodialysis on prevalent patients
Detailed Description
The novel coronavirus disease (COVID-19), also known as COVID-19 (and SARS-Cov2) by the World Health Organization, is a rapidly evolving pandemic. The outbreak is expected to infect a large portion of...
Eligibility Criteria
Inclusion
- More than 30 days of Chronic ambulatory in-center hemodialysis
Exclusion
- More than three sessions a week
- amputated lower limbs
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04374058
Start Date
March 20 2020
End Date
March 1 2021
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dialisis Madariaga
General Juan Madariaga, Buenos Aires, Argentina, 7167